Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
TVM
Biotech
Lilly regains an oncology asset in up-to-$575M AurKa deal
Eli Lilly is handing over $110 million up front for AurKa Pharma, regaining an asset it sold off in 2016.
Amirah Al Idrus
May 14, 2018 10:50am
Rapid Micro bags $60M to grow microbial detection business
May 2, 2018 12:01am
Centogene raises $28M to fuel expansion in the U.S. and China
Jun 14, 2017 2:23am
Neurimmune, TVM set up ALS biotech, secure Lilly support
Dec 7, 2016 7:21am
